Literature DB >> 27173462

Hyperglycemic clamp-derived disposition index is negatively associated with metabolic syndrome severity in obese subjects.

Sapna S Shah1, Claudia E Ramirez2, Alvin C Powers3, Chang Yu4, Cyndya A Shibao5, James M Luther6.   

Abstract

OBJECTIVE: Metabolic syndrome is associated with insulin resistance and increased future risk of type 2 diabetes. This study investigates the relationship between insulin secretion, insulin resistance and individual metabolic syndrome components in subjects without a prior diagnosis of diabetes. RESEARCH DESIGN AND METHODS: We assessed insulin secretion during hyperglycemic clamps by infusing dextrose to maintain hyperglycemia (200mg/dL), followed by L-arginine administration. Studies in 98 individuals (mean age 45.3±1.2years, 56% female, 22% African-American, 49% with metabolic syndrome) were analyzed. We tested the association between the number of metabolic syndrome components and individual outcome variables using linear mixed-effects models to adjust for potential confounding effects of age, sex, and race.
RESULTS: Insulin sensitivity index was reduced in the presence of 1 or more metabolic syndrome components. Insulin sensitivity was independently associated with age, waist circumference, male gender and decreased HDL cholesterol. The acute insulin response was greater with two or more metabolic syndrome components, and late glucose-stimulated and L-arginine-stimulated insulin responses exhibited a similar trend. In contrast, the disposition index, a measure of beta cell compensation for insulin resistance, was linearly lower with the number of metabolic syndrome components, and was negatively associated with age, Caucasian race, waist circumference, fasting glucose, and decreased HDL cholesterol.
CONCLUSIONS: The insulin secretory response in metabolic syndrome is inadequate for the worsening insulin sensitivity, as demonstrated by a decline in disposition index. A dysfunctional insulin secretory response is evident in non-diabetic individuals and worsens with accumulation of metabolic syndrome components.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Disposition Index; Insulin secretion; Insulin sensitivity; Metabolic syndrome

Mesh:

Substances:

Year:  2016        PMID: 27173462      PMCID: PMC4867079          DOI: 10.1016/j.metabol.2016.02.011

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  41 in total

Review 1.  Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.

Authors:  Scott M Grundy; H Bryan Brewer; James I Cleeman; Sidney C Smith; Claude Lenfant
Journal:  Circulation       Date:  2004-01-27       Impact factor: 29.690

2.  Role of dietary factors in ethnic differences in early risk of cardiovascular disease and type 2 diabetes.

Authors:  C H Lindquist; B A Gower; M I Goran
Journal:  Am J Clin Nutr       Date:  2000-03       Impact factor: 7.045

3.  Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study.

Authors:  F L Brancati; W H Kao; A R Folsom; R L Watson; M Szklo
Journal:  JAMA       Date:  2000-05-03       Impact factor: 56.272

Review 4.  Accurate assessment of beta-cell function: the hyperbolic correction.

Authors:  Richard N Bergman; Marilyn Ader; Katrin Huecking; Gregg Van Citters
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

5.  Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.

Authors:  W K Ward; D C Bolgiano; B McKnight; J B Halter; D Porte
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

6.  Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.

Authors:  J Eriksson; A Franssila-Kallunki; A Ekstrand; C Saloranta; E Widén; C Schalin; L Groop
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

7.  Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome.

Authors:  Anthony J G Hanley; Lynne E Wagenknecht; Ralph B D'Agostino; Bernard Zinman; Steven M Haffner
Journal:  Diabetes       Date:  2003-11       Impact factor: 9.461

8.  The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study.

Authors:  Carlos Lorenzo; Mayor Okoloise; Ken Williams; Michael P Stern; Steven M Haffner
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

9.  Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Authors:  R A DeFronzo; J D Tobin; R Andres
Journal:  Am J Physiol       Date:  1979-09

10.  Insulin response in relation to insulin sensitivity: an appropriate beta-cell response in black South African women.

Authors:  Julia H Goedecke; Joel A Dave; Mirjam V Faulenbach; Kristina M Utzschneider; Estelle V Lambert; Sacha West; Malcolm Collins; Tommy Olsson; Brian R Walker; Jonathan R Seckl; Steven E Kahn; Naomi S Levitt
Journal:  Diabetes Care       Date:  2009-02-05       Impact factor: 17.152

View more
  6 in total

1.  Lipids and ketones dominate metabolism at the expense of glucose control in pulmonary arterial hypertension: a hyperglycaemic clamp and metabolomics study.

Authors:  Jacob T Mey; Adithya Hari; Christopher L Axelrod; Ciarán E Fealy; Melissa L Erickson; John P Kirwan; Raed A Dweik; Gustavo A Heresi
Journal:  Eur Respir J       Date:  2020-04-09       Impact factor: 16.671

2.  Human PAH is characterized by a pattern of lipid-related insulin resistance.

Authors:  Anna R Hemnes; J Matthew Luther; Christopher J Rhodes; Jason P Burgess; James Carlson; Run Fan; Joshua P Fessel; Niki Fortune; Robert E Gerszten; Stephen J Halliday; Rezzan Hekmat; Luke Howard; John H Newman; Kevin D Niswender; Meredith E Pugh; Ivan M Robbins; Quanhu Sheng; Cyndya A Shibao; Yu Shyr; Susan Sumner; Megha Talati; John Wharton; Martin R Wilkins; Fei Ye; Chang Yu; James West; Evan L Brittain
Journal:  JCI Insight       Date:  2019-01-10

3.  Primary Aldosteronism Decreases Insulin Secretion and Increases Insulin Clearance in Humans.

Authors:  Gail K Adler; Gillian R Murray; Adina F Turcu; Hui Nian; Chang Yu; Carmen C Solorzano; Robert Manning; Dungeng Peng; James M Luther
Journal:  Hypertension       Date:  2020-03-16       Impact factor: 10.190

4.  Time to the Peak, Shape of the Curve and Combination of These Glucose Response Characteristics During Oral Glucose Tolerance Test as Indicators of Early Beta-cell Dysfunction in Obese Adolescents

Authors:  Lavinia La Grasta Sabolić; Marija Požgaj Šepec; Maja Cigrovski Berković; Gordana Stipančić
Journal:  J Clin Res Pediatr Endocrinol       Date:  2020-10-02

5.  Experimental BPA Exposure and Glucose-Stimulated Insulin Response in Adult Men and Women.

Authors:  Richard W Stahlhut; John Peterson Myers; Julia A Taylor; Angel Nadal; Jonathan A Dyer; Frederick S Vom Saal
Journal:  J Endocr Soc       Date:  2018-09-12

6.  A Systematic Review of Beta Cell Function in Adults of Black African Ethnicity.

Authors:  M Ladwa; O Hakim; S A Amiel; L M Goff
Journal:  J Diabetes Res       Date:  2019-10-20       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.